Skip to main content

Table 1 Assessment protocol for the current study from V1 to V5

From: Pharmacogenomic study on anti-VEGF medicine in treatment of macular Neovascular diseases: a study protocol for a prospective observational study

Visit of data entry

V1

V2

V3

V4

V5

Meets enrollment / exclusion criteria

X

    

Month

 

1

3

6

12

Days

 

30 (± 7) days after first injection

90 (± 7) days after first injection

180 (± 7) days after first injection

360 (± 7) days after first injection

Consent form

X

    

Demographic data

X

    

Systemic and ocular disease history

X

    

Best corrected visual acuity

X

X

X

X

X

Optical coherence tomography

X

X

X

X

X

Accompanying medication

X

X

X

X

X

Data record

X

X

X

X

X

Treatment program records

 

X

X

X

X

Adverse events

X

X

X

X

X